Jetra Therapeutics is a preclinical biotechnology company developing a novel engineered protein for the treatment of obesity-related liver diseases including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitus (NASH).
Jetra Therapeutics is a spin-out of the University of Queensland, founded on intellectual property developed at Mater Research Institute (MRI-UQ) and licensed by UQ’s technology transfer company, UniQuest.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Brisbane, Qld 4067, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Chemical Manufacturing.
- HQ
- Brisbane, Qld
Jetra Therapeutics Questions
Jetra Therapeutics's website is https://www.jetratherapeutics.com/
Jetra Therapeutics's LinkedIn profile is https://au.linkedin.com/company/jetra-therapeutics
Jetra Therapeutics has
3 employees.
View email and phone details for 3
employees at Jetra Therapeutics.
Jetra Therapeutics's industry is
Biotechnology Research
Jetra Therapeutics's top competitors are
Inia Health / Mindcheck,
Leorah Clinical Pty. Ltd.,
Funky Fungus,
Westmead Research Hub Emcr Network,
Charles Perkins Centre Emcr,
Cre Respond,
Resseptor Therapeutics,
Bioessence Consultancy Services,
Rage Biotech,
De Groot Technical Services.
Jetra Therapeutics's categories are Biotechnology Research
Jetra Therapeutics's founding year is 2019
